Anna Bych

Anna Bych

Auto-generated profile, based on publicly available information

Anna Bych

Biziel University Hospital in Bydgoszcz, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
ZKZuzanna Kordyś-Wyrobek
Zuzanna Kordyś-Wyrobek
MSMarcelina Skajewska
Marcelina Skajewska
MLMaciej Lazarek
Maciej Lazarek
MIMagdalena Iwaszko
Magdalena Iwaszko
AKAlicja Kamińska
Alicja Kamińska
KRKrzysztof Reazka
Krzysztof Reazka
Age-related macular degeneration (AMD) is one of the leading causes of irreversible central vision impairment in older adults. The introduction of intravitreal vascular endothelial growth factor (VEGF) inhibitors has fundamentally changed the prognosis of neovascular AMD (nAMD). Contemporary research focuses both on maintaining functional efficacy while reducing treatment burden and on developing effective therapies for geographic atrophy (GA). The aim of this review is to critically evaluate selected contemporary therapeutic strategies used or investigated in AMD, with particular emphasis on efficacy, safety, durability of treatment effect, and the quality of available evidence. The evidence evaluated primarily comprised randomized controlled trials, systematic reviews, and meta-analyses, supplemented by early-phase clinical trials for experimental technologies and post-marketing data when relevant safety signals were identified. The most mature body of evidence demonstrating preservation or improvement of visual function in nAMD concerns anti-VEGF therapy. The PULSAR and TENAYA/LUCERNE trials demonstrated that aflibercept 8 mg and faricimab, respectively, can be administered at extended treatment intervals while maintaining non-inferior functional efficacy compared with active comparators [8–11]. The ranibizumab Port Delivery System (PDS) represents an alternative strategy for reducing the frequency of intravitreal injections but requires surgical implantation [17,18]. In GA, the complement inhibitors pegcetacoplan and avacincaptad pegol have demonstrated modest reductions in the rate of anatomical disease progression [32–34]. These effects should not be interpreted as retinal regeneration or as necessarily translating into improved visual function. For pegcetacoplan, post-marketing safety signals are also clinically relevant [41]. The European Medicines Agency (EMA) did not grant marketing authorization for Syfovre in the European Union, concluding that the demonstrated reduction in GA lesion growth did not translate into a sufficiently meaningful clinical benefit for patients to establish a positive benefit-risk balance [42]. Photobiomodulation demonstrated statistically significant functional outcomes in the LIGHTSITE III program; however, its evidence base remains substantially smaller than that supporting anti-VEGF therapy [35,36]. Gene therapies represent a promising investigational approach, but current evidence is derived predominantly from early-phase studies and is insufficient to establish these treatments as equivalent or superior alternatives to standard anti-VEGF therapy [37,38].

31 December 2025 in Quality in Sport
Verified
Journal Article
Open access
LWLidia Wydeheft
Lidia Wydeheft
PMPaulina Malon
Paulina Malon
ABAnna Bych
Anna Bych
PHPaulina Halik
Paulina Halik
JJJustyna Jusiak
Justyna Jusiak
KKKornelia Kędziora-Kornatowska
Kornelia Kędziora-Kornatowska
IntroductionThe aging population has increased the number of older adults undergoing elective surgery, making safe, individualized general anesthesia essential. Age-related physiological changes—such as reduced cardiac, pulmonary, hepatic, and renal reserve, multimorbidity, frailty, and altered body composition—affect drug metabolism, pharmacodynamics, and tolerance to perioperative stress, resulting in higher rates of cardiovascular, respiratory, and cognitive complications compared with younger adults.ResultsOlder patients require careful dose adjustments due to reduced drug clearance and increased sensitivity to anesthetics. Propofol-based total intravenous anesthesia (TIVA), EEG-guided depth monitoring, and agents like etomidate or dexmedetomidine improve hemodynamic stability and reduce postoperative cognitive dysfunction (POCD) and delirium. Comprehensive preoperative evaluation—including frailty screening, cognitive and functional assessment, and medication review—helps identify high-risk patients. Postoperative vigilance is needed to manage respiratory depression, inadequate pain control, and prolonged recovery. Telemedicine has proven effective for pre-anesthetic assessment, enabling early detection of cognitive impairment and reducing time, cost, and travel burden.DiscussionPersonalized anesthesia considering frailty, comorbidities, and altered drug metabolism improves safety. Minimizing anesthetic duration, selecting safer agents, EEG guidance, and TIVA support better outcomes, while telemedicine enhances patient-centered care.ConclusionGeneral anesthesia in older adults requires tailored strategies addressing age-related changes and increased perioperative vulnerability. Individualized dosing, careful agent selection, structured preoperative assessment, postoperative monitoring, and telemedicine support can enhance safety and outcomes, highlighting key differences from younger patients and emphasizing a holistic, evidence-based perioperative approach.

31 December 2025 in OphthaTherapy. Therapies in Ophthalmology
Verified
Journal Article
Open access
PDF file
PMPaulina Malon
Paulina Malon
SKSzymon Konczyński
Szymon Konczyński
ABAnna Bych
Anna Bych
KKKarolina Kaźmierczak
Karolina Kaźmierczak
Introduction: Autoimmune thyroid diseases such as Hashimoto’s thyroiditis (HT) and Graves’ disease (GD) can present with ocular manifestations. While these are well documented in GD, less is known about their prevalence and characteristics in HT.Methods: This narrative review summarizes current knowledge on the epidemiology, pathophysiology, clinical features, diagnostics, and treatment of ophthalmic symptoms in HT and GD. Special focus is placed on dry eye syndrome, thyroid-associated ophthalmopathy (TAO), and diagnostic approaches including imaging and tear biomarker analysis.Results: HT most frequently presents with dry eye syndrome, eyelid edema, and rare manifestations like diplopia or vision loss. TAO, typically associated with GD, is also observed in a small percentage of HT cases. GD-related orbitopathy affects up to 50% of patients and may lead to severe complications, including optic neuropathy. Several immunological markers, including TSHR and IGF-1R, play a key role in the pathogenesis of Graves’ orbitopathy (GO).Conclusion: Ocular symptoms in HT and GD are diverse and can significantly impact patients’ quality of life. Although GO is more characteristic of GD, its presence in HT should not be underestimated. Comprehensive ophthalmologic evaluation is essential for timely diagnosis and treatment.

21 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
ABAnna Bych
Anna Bych
ZKZuzanna Kordyś-Wyrobek
Zuzanna Kordyś-Wyrobek
MLMaciej Lazarek
Maciej Lazarek
AKAlicja Kamińska
Alicja Kamińska
ESEmilia Stachula-Mielczarek
Emilia Stachula-Mielczarek
KRKrzysztof Reszka
Krzysztof Reszka
Introduction and purpose: The aim of the study was to present and briefly discuss the causes of infections of deep neck tissues in geriatric patients. The issue of such factors as multiple diseases, surgical and dental procedures or pharmacotherapy in the geriatric population, which have a significant impact on the course of infection, was discussed. Material and Methods: PubMed, ClinicalKey, and ClinicalTrials.gov were searched for material discussing the course of deep neck tissue infections in the senior population. The works and research from the years 2014-2026 were used, searching for terms such as "deep neck infection", "deep neck infection elderly", "deep neck infection geriatrics", "DNI elderly", "DNI geriatrics", "deep neck infection" age ". The aim was to show the course of DNI in the geriatric population and what mechanisms influence the course of the infections in this age group. Results: Despite the fact that infections of deep neck tissues occur in all age groups, the geriatric population is particularly vulnerable to their aggressive course due to the presence of numerous risk factors, such as taking immunosuppressive drugs, lowered immunity or the presence of comorbidities. Conclusions: There are problems with the diagnosis and treatment of DNI, especially in the elderly population, where the course of these infections may be different than in other age groups. Improper management may lead to health and life-threatening complications. The role of oral health prophylaxis is also very important, and it often does not reach geriatric patients sufficiently.

28 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
ZKZuzanna Kordyś-Wyrobek
Zuzanna Kordyś-Wyrobek
MLMaciej Lazarek
Maciej Lazarek
ABAnna Bych
Anna Bych
Obesity is a condition affecting an increasing number of people worldwide, to the point where it has reached pandemic proportions - "globesity". It significantly increases the risk of other co-morbidities, including cardiovascular disease, dyslipidaemia and type 2 diabetes. Obesity is a serious problem, not only in terms of health but also socio-economically. It is currently believed that bariatric surgery is the most effective method of treating morbid obesity and reducing the risk of associated conditions. Some healthcare professionals harbour negative preconceptions about people with obesity, which is why it is important to train interdisciplinary medical staff in how to collaborate with bariatric patients. In bariatric surgery, this is particularly crucial as it helps to ensure the expected outcomes of the operation are achieved and leads to a significant reduction in the risk of complications.

16 July 2026 in OphthaTherapy. Therapies in Ophthalmology
Verified
Journal Article
Open access
PDF file
PMPaulina Malon
Paulina Malon
ABAnna Bych
Anna Bych
SKSzymon Konczyński
Szymon Konczyński
KKKarolina Kaźmierczak
Karolina Kaźmierczak
Acquired retinal toxicity represents an important and potentially vision-threatening complication of medical therapies, surgical procedures and environmental exposures. It may result from phototoxic injury, intraocular dyes, intravitreal medications or long-term systemic drug use. Advances in retinal imaging have improved early detection. However, retinal damage is often irreversible once established. Understanding the mechanisms, risk factors, and clinical manifestations of retinal toxicity is essential for prevention, timely diagnosis and optimal patient management. This review summarizes the main mechanisms of acquired retinal toxicity, illustrates them with representative clinical cases and discusses current strategies for prevention and management.